<i>CYP3A4*22</i> may increase bleeding risk in ticagrelor users

Hilkka Liedes, Juha Pajula, Anna‐Leena Vuorinen, Francesco De Pretis, Mark van Gils, Kari Harno, Mika Lehto, Mikko Niemi, Jaakko Lähteenmäki

Open source

DOI: 10.1111/bcpt.13884
Published: 2023-05-31
Container: Basic & Clinical Pharmacology & Toxicology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.13884,
  title = {<i>CYP3A4*22</i> may increase bleeding risk in ticagrelor users},
  author = {Hilkka Liedes and Juha Pajula and Anna‐Leena Vuorinen and Francesco De Pretis and Mark van Gils and Kari Harno and Mika Lehto and Mikko Niemi and Jaakko Lähteenmäki},
  year = {2023},
  journal = {Basic \&amp; Clinical Pharmacology \&amp; Toxicology},
  doi = {10.1111/bcpt.13884},
  url = {https://doi.org/10.1111/bcpt.13884}
}

RIS

TY  - JOUR
TI  - <i>CYP3A4*22</i> may increase bleeding risk in ticagrelor users
AU  - Hilkka Liedes
AU  - Juha Pajula
AU  - Anna‐Leena Vuorinen
AU  - Francesco De Pretis
AU  - Mark van Gils
AU  - Kari Harno
AU  - Mika Lehto
AU  - Mikko Niemi
AU  - Jaakko Lähteenmäki
PY  - 2023
JO  - Basic &amp; Clinical Pharmacology &amp; Toxicology
DO  - 10.1111/bcpt.13884
UR  - https://doi.org/10.1111/bcpt.13884
ER  -

APA

Liedes, H., Pajula, J., Vuorinen, A., Pretis, F. D., Gils, M. V., Harno, K., Lehto, M., Niemi, M., & Lähteenmäki, J. (2023). <i>CYP3A4*22</i> may increase bleeding risk in ticagrelor users. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13884

Source records

crossref · retrieved 2026-09-26T10:25:03.004Z